
Results
13
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
13 companies
Merck KGaA
Market Cap: €53.3b
Operates as a science and technology company in Germany and internationally.
MRK
€122.60
7D
1.7%
1Y
-12.4%
Bayer
Market Cap: €36.4b
Operates as a life science company worldwide.
BAYN
€37.01
7D
3.0%
1Y
91.6%
SCHOTT Pharma KGaA
Market Cap: €2.3b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€15.10
7D
1.3%
1Y
-40.0%
Dermapharm Holding
Market Cap: €2.1b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMP
€39.35
7D
2.2%
1Y
1.2%
Evotec
Market Cap: €966.4m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€5.45
7D
1.2%
1Y
-33.5%
PEPTONIC medical
Market Cap: €560.2m
A medical technology company, develops and sells intimate self-care products for women.
28L
€0.0002
7D
0%
1Y
0%
MPH Health Care
Market Cap: €95.9m
An investment company, engages in the healthcare business in Germany.
93M1
€22.40
7D
0%
1Y
0.9%
Darwin
Market Cap: €93.0m
Operates in the healthcare industry.
7V0
€7.75
7D
0%
1Y
n/a
2invest
Market Cap: €63.4m
An investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, IT sectors, and natural resources sectors in Germany and internationally.
2INV
€11.50
7D
0%
1Y
-1.7%
Genetic Analysis
Market Cap: €48.4m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
8V8
€0.043
7D
4.9%
1Y
68.7%
Cantourage Group
Market Cap: €42.3m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€3.39
7D
0%
1Y
-33.5%
Biofrontera
Market Cap: €14.8m
A biopharmaceutical company, engages in the research, development, and distribution of dermatological products in Germany, Spain, the United Kingdom, rest of Europe, the United States, and internationally.
B8FK
€2.44
7D
2.5%
1Y
13.5%
Respiratorius
Market Cap: €12.8m
A research company, develops pharmaceuticals for the treatment of cancer.
HF00
€0.13
7D
4.4%
1Y
-76.1%